Carlos Felimer del Valle Rojas
Universidad de La Frontera
H-index: 27
Latin America-Chile
Top articles of Carlos Felimer del Valle Rojas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
CNS efficacy of osimertinib with or without chemotherapy in epidermal growth factor receptor–mutated advanced non–small-cell lung cancer | Journal of Clinical Oncology | Pasi A Jänne David Planchard Kunihiko Kobayashi Ying Cheng Chee Khoon Lee | 2024/3/1 |
Adjuvant nivolumab monotherapy vs placebo for localized renal cell carcinoma at high risk of relapse after nephrectomy: Results from Part B of the randomized, phase 3 CheckMate … | Robert J Motzer Axel Bex Paul Russo Yoshihiko Tomita Hernan Cutuli | 2024/2/1 | |
A phase 1, open-label, multicenter study evaluating MK-1084 as monotherapy and in combination with other therapies in patients with KRAS G12C mutant … | Iwona A Lugowska Carlos Rojas Anastasios Stathis Susanne Weindler Abhijit Pal | 2024/1/20 | |
Digital materialisms. Beyond the media ecosystem | Inmediaciones de la Comunicación | Carlos Del Valle Rojas Mauro Salazar Jaque | 2024/6 |
Phase 2 study of pembrolizumab plus lenvatinib and belzutifan in patients with metastatic esophageal squamous cell carcinoma. | Carlos Rojas Baek-Yeol Ryoo Sun Young Rha Robin Kate Kelley Ayala Hubert | 2024/1/20 | |
Materialismos digitales. Más allá del ecosistema de medios | Inmediaciones de la Comunicación | Carlos Del Valle Rojas Mauro Salazar Jaque | 2024/6 |
Abstract CT095: Phase 1 evaluation of triple therapy with boserolimab (anti-CD27 agonist), pembrolizumab, and chemotherapy in patients with triple-negative breast cancer (TNBC … | Cancer Research | Carlos Rojas Bernard Gaston Doger de Spéville Seock-Ah Im Ronnie Shapira-Frommer María De Miguel | 2024/4/5 |
1534P First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (mESCC): Safety run-in results from the … | Annals of Oncology | JM Sun CY Lin C Rojas F Rivera D Kwong | 2023/10/1 |
Condylar femoral arthroplasty with bone cement as a salvage measure in open fracture with articular bone defect in a young patient | Trauma Case Reports | Rodrigo Olivieri Nicolás Franulic Felipe Ahumada Matías Harmat José Laso | 2023/12/1 |
Bempegaldesleukin plus nivolumab in untreated advanced melanoma: the open-label, phase III PIVOT IO 001 trial results | Journal of Clinical Oncology | Adi Diab Helen Gogas Shahneen Sandhu Georgina V Long Paolo A Ascierto | 2023/10/20 |
[Translated article] The use of arthroscopy does not increase the incidence of complications in the management of Schatzker IV–VI tibial plateau fractures | Revista espanola de cirugia ortopedica y traumatologia | Nicolás Franulic C Brito C Del Pino J Laso C Rojas | 2023/7/1 |
Modelos Universitarios y Gobierno Corporativo. Trayectorias del capitalismo académico | Revista de Sociología | Mauro Salazar Carlos del Valle Rojas | 2023 |
Vitruvius+: an area-efficient RISC-V decoupled vector coprocessor for high performance computing applications | ACM Transactions on Architecture and Code Optimization | Francesco Minervini Oscar Palomar Osman Unsal Enrico Reggiani Josue Quiroga | 2023/3/1 |
663P Safety and preliminary efficacy of the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC | Annals of Oncology | C Rojas I Lugowska R Juergens A Sacher S Weindler | 2023/10/1 |
Respuesta a carta: Conocimiento sobre la prevalencia y epidemiología en hepatitis autoinmune | Revista colombiana de Gastroenterología | Gabriel Sebastian Díaz Ramírez Diego Fernando Jiménez Diana Escobar Carlos Vargas Carlos Rojas | 2023/9/27 |
Sargantana: An Academic SoC RISC-V Processor in 22nm FDSOI Technology | Max Doblas Gerard Candón Xavier Carril Marc Domínguez Enric Erra | 2023/11/15 | |
Revista Española de Cirugía Ortopédica y Traumatología | MC Ponce de León Samper G Herrera Ortiz C Castellanos Mendoza | 2014 | |
Word retrieval after the 80s: Evidence from specific and multiple words naming tasks | Sage Open | Carlos Rojas Bernardo Riffo Ernesto Guerra | 2023/5 |
First-line lenvatinib plus pembrolizumab plus chemotherapy versus chemotherapy in advanced/metastatic gastroesophageal adenocarcinoma (LEAP-015): Safety run-in results. | Patricio Eduardo Yanez Irit Ben-Aharon Carlos Rojas Daniel Acosta Eyzaguirre Ayala Hubert | 2023/2/1 | |
OP07. 08: How bad is it to keep selective technique for TTTS? | Ultrasound in Obstetrics & Gynecology | M Yamamoto H Figueroa D Pedraza J Astudillo S Biancardi | 2023/10 |
